Clinical trials
Phase 4 Ischemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 17 |
| Unknown status | 7 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laval University | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Artgen Biotech | 1 |
| Beth Israel Deaconess Medical Center | 1 |
| Biosense Webster, Inc. | 1 |
| Cedars-Sinai Medical Center | 1 |
| Charite University, Berlin, Germany | 1 |
| Deutsches Herzzentrum Muenchen | 1 |
| Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III | 1 |
| Imam Abdulrahman Bin Faisal University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemia | 35 |
| Myocardial Infarction | 6 |
| Coronary Artery Disease | 5 |
| Stroke | 5 |
| Cardiovascular Diseases | 4 |
| Heart Diseases | 4 |
| Thrombosis | 3 |
| Chronic Limb-Threatening Ischemia | 2 |
| Diabetes Mellitus | 2 |
| Embolism | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.